♥️VT Hematology and Medical Oncology Fellowship at the UVM Medical Center youtu.be/fltYn2VrdIM via YouTube

CAR-T in 2L DLBCL - differences in study designs/populations likely explain different outcomes. Thanks to manalikamdar for help with the slide #lymsm #ASH21

This CBS halftime show with the music blasting right behind them is hilarious they re using sign language 😂😂#KCvsCIN

It's #fellowship application season again! Here's a little peek into our program! UVM Cancer Center UVM Medical Center #hematology #oncology #MedTwitter youtube.com/watch?v=fltYn2…

What’s new in myeloma? 1/ Frontline treatment: We are recommending quadruplets as initial therapy for more patients, especially as pre transplant induction for high risk myeloma. My preferred quadruplet is Dara-VRd.

4/ Autologous stem cell transplant: Transplant remains important for all eligible patients. But the DETERMINATION trial results confirm that the timing of transplant (frontline versus at relapse) has similar overall survival. Patient choice will be an important factor.

5/ Post transplant maintenance: Cassiopeia trial shows no added benefit of daratumumab maintenance in patients who got daratumumab as part of induction. Given this result, the cost, and the risk of toxicity, I don’t recommend adding Dara for maintenance. Need more data.

8/ Cost of myeloma drugs: Bortezomib SQ generic is now available in the US at a fraction of the price of brand name Velcade. Only $200 a dose. Use the generic. Not the brand name.

#VermontFoliage mybackyard

7 years ago today, Jurgen Klopp joined Liverpool. The rest is history. #MyPLMorning

Looking for oncologists for the UVM system in Vermont! Community/academic opportunity with specialty focus opportunities! J-1 welcome to apply! ALL applicants must apply online at:  uvmjobs.com under Position No. #00021745 #MedTwitter #oncology UVM Cancer Center

If you're looking to do post-doc research in cognition epidemiology, come work with my group UVM Larner Med Debora Kamin Mukaz, PhD,MS 🫀🐳🇨🇩 UVMHeartBrain #AHA22

♥️ and 🧠 Health: Next is Mansour Gergi MD presenting on optimizing #cardiovascular care in patients with #cancer

Cancer drug shortages have led to “gut-wrenching options, delays in treatment and potentially bleaker futures” for patients. Great article on human impact and difficult choices by ⁦Christina Jewett⁩ via ⁦The New York Times⁩ nytimes.com/2023/06/26/hea…

Another great #ASH2023, but as tradition dictates, here is a pic of the paper waste sent to my room. ASH - time to stop this wasteful practice.

Time for some bling, and💰💰! Congratulations to Mansour Gergi MD, the new University of Vermont Green & Gold Early Career Professor of our Dept of Medicine! He is studying hospital acquired bleeding in cancer patients, a critical topic. UVM Larner Med UVM Cancer Center

Ready for gameday #myplmorning #NBCPremierLeague #Liverpool #LIVMUN